Case Presentation: A 50-Year-Old Man With Metastatic CRC (mCRC)

Opinion
Video

Christina S. Wu, MB, BCh, MD, presents the case of a 50-year-old man with metastatic colorectal cancer to the panel for discussion.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      Recent Videos
      Epithelioid Sarcoma: Histological Features and Differential Diagnoses
      Epithelioid Sarcoma: Histological Features and Differential Diagnoses
      Epithelioid Sarcoma: Overview and Presentation
      Epithelioid Sarcoma: Overview and Presentation
      4 experts in this video
      Leveraging PSMA PET Imaging in Posttreatment Response Assessment: Evolving Practices and Data Insights
      2 experts in this video
      Decision-Making Factors in Choosing Combination Therapies in EGFR-Mutated NSCLC
      2 experts in this video
      Evaluating Chemotherapy-Free vs Chemotherapy-Containing Combos in First-Line EGFR-Mutated NSCLC: Pros and Cons
      4 experts in this video
      Role of PSMA PET Imaging in Guiding Surgical Treatment Decisions in Prostate Cancer
      Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
      Outlining Ongoing Clinical Developments in Treatment for Rare Lymphomas
      Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
      Addressing Racial Disparities, Social Barriers to Breast Cancer Care
      177Lu Marks Practice-Changing Approval in Metastatic CRPC
      177Lu Marks Practice-Changing Approval in Metastatic CRPC
      A paucity of prospective, well-vetted data to guide therapy in patients with rare lymphomas may result in a reliance on expert consensus guidelines.
      Highlighting Challenges to Patient Treatment in Rare Lymphomas
      Related Content
      A Variety of Treatment Options Are Becoming Available in CRC

      A Variety of Treatment Options Are Becoming Available in CRC

      ONCOLOGY Staff
      December 31st 2023
      Article

      Kristen K. Ciombor, MD, MSCI, gives an overview of the current treatment landscape for patients with metastatic colorectal cancer.

      New treatment updates could help find more patient subtypes to target and treat in the world of CRC.

      Multidisciplinary Care and New Treatment Options in CRC

      Kristen K. Ciombor, MD, MSCI
      November 20th 2023
      Podcast

      New treatment updates could help find more patient subtypes to target and treat in the world of CRC, according to Kristen K. Ciombor, MD, MSCI.

      Cabozantinib plus nivolumab and ipilimumab appears to improve progression-free survival vs cabozantinib alone among patients with metastatic soft-tissue sarcoma in a phase 2 trial.

      Cabozantinib Combo Yields Disease Control in Metastatic Soft Tissue Sarcoma

      Brielle Benyon
      June 5th 2023
      Article

      Cabozantinib plus nivolumab and ipilimumab appears to improve progression-free survival vs cabozantinib alone among patients with metastatic soft-tissue sarcoma in a phase 2 trial.

      Collaboration in kidney cancer palliative care and integrative medicine programs underscores the current development of University Hospitals’ integrative oncology wing.

      Expert Outlines Collaborative Integrative Oncology Plans in Kidney Cancer

      Santosh Rao, MD
      April 10th 2023
      Article

      Collaboration in kidney cancer palliative care and integrative medicine programs underscores the current development of University Hospitals’ integrative oncology wing.